| Typicality: | 0.351 |
| Saliency: | 0.236 |
| as a precautionary measure | 3 | purpose |
| on prescription drugs | 2 | transitive-object |
| incentive → reduce → spending | 7 |
| incentive → cut → spending | 3 |
| negative | neutral | positive |
| 0.342 | 0.426 | 0.232 |
| Raw frequency | 10 |
| Normalized frequency | 0.236 |
| Modifier score | 0.500 |
| Perplexity | 191.867 |